Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 7:33 PM
Ignite Modification Date: 2025-12-25 @ 5:15 PM
NCT ID: NCT05201703
Description: None
Frequency Threshold: 0
Time Frame: 4 months per participant assessment (2 months of baseline and 2 months of treatment)
Study: NCT05201703
Study Brief: Fycompa in Catamenial Epilepsy
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Fycompa 4 mg Daily Fycompa: Fycompa 4 mg daily 0 None 0 1 0 1 View
Fycompa 4 mg Daily With a Boost to 6 mg Daily Fycompa with a boost: Fycompa 4 mg daily with a boost to 6 mg daily a week before the start of your menstruation cycle until Day 4 of your cycle. 0 None 0 3 1 3 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Feeling off SYSTEMATIC_ASSESSMENT Nervous system disorders None View